Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors (Q29035867)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 7 February 2007)

Language	Label	Description	Also known as
English	Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors	scientific article (publication date: 7 February 2007)

Statements

scholarly article

0 references

Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors (English)

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

phase I clinical trial

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

object named as

E. Claire Dees

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

author name string

Thomas E. Stinchcombe

1

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Mark A. Socinski

2

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Christine M. Walko

3

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Bert H. O’Neil

4

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Frances A. Collichio

5

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Anastasia Ivanova

6

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Hua Mu

7

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Michael J. Hawkins

8

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Richard M. Goldberg

9

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Celeste Lindley

10

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

publication date

7 February 2007

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Cancer Chemotherapy and Pharmacology

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

60

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

5

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

759-766

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

6 April 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

6 April 2017

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

7 April 2017

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

3 June 2018

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

3 June 2018

The taxanes: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

3 June 2018

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

3 June 2018

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

3 June 2018

Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

26 November 2018

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

26 November 2018

Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

26 November 2018

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

26 November 2018

Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2860386

26 November 2018

Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17285317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17285317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin plus paclitaxel combination chemotherapy: impact of sequence of drug administration on treatment-induced neutropenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17285317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17285317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre

1 reference

https://pubmed.ncbi.nlm.nih.gov/17285317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of neurotoxicity following repeated cremophor/ethanol injections in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17285317

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00280-007-0423-X

1 reference

DOI.org query endpoint

https://doi.org/10.1007%2FS00280-007-0423-X

27 March 2017

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29035867&oldid=2177933691"